Clinical Trials Logo

Type 2 Diabetes Mellitus clinical trials

View clinical trials related to Type 2 Diabetes Mellitus.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT02660476 Suspended - Diabetes Mellitus Clinical Trials

Qatar Universal Diabetes Outcomes (QUDOS) Study

QUDOS
Start date: October 2014
Phase:
Study type: Observational

QUDOS is a cross-sectional population study aiming to answer key questions about diabetes and its complications in Qatar as well as identify factors associated with the development and progression of diabetes complications.

NCT ID: NCT02026232 Suspended - Clinical trials for Type 2 Diabetes Mellitus

Metabolic Effects of Hydroxychloroquine

MetaHcQ
Start date: March 2012
Phase: N/A
Study type: Interventional

The basic plan of the study is to randomize otherwise healthy subjects with type 2 diabetes to hydroxychloroquine, 200 mg twice daily or placebo.

NCT ID: NCT01162694 Suspended - Clinical trials for Type 2 Diabetes Mellitus

Comparing Internet Blood Glucose Monitoring System and Continuous Glucose Monitoring System

Start date: July 2010
Phase: N/A
Study type: Interventional

Management of type 2 diabetes is an ongoing challenge for patients and their doctors. In order to prevent short and long term complications, patients need to monitor and control their blood sugar levels. In addition, they may need to have an ongoing communication with their doctor in order to modify treatment. In this study the investigators wish to compare two systems of monitoring and communication of blood sugar levels. The first is the use of continuous glucose monitoring system and the second is the use of an Internet-based glucose monitoring system. The investigators want to compare their effect and/or benefits.

NCT ID: NCT01060241 Suspended - Clinical trials for Type 2 Diabetes Mellitus

Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM) on Combination Oral Therapy

Start date: February 2010
Phase: N/A
Study type: Interventional

This project will test the effectiveness of an Internet based glucose monitoring system on the A1C levels of patients with type 2 diabetes. All of the patients are given a meter and test strips to test their blood glucose levels, however, half of them will be required to also upload their meter onto the Internet which can then be viewed by their endocrinologist. The doctor can then send a message back to the patient and comment on the readings. The effect of the ongoing communication will be measured by the changes in the glucose levels (HbA1C) over 3 and 6 months.

NCT ID: NCT01044368 Suspended - Clinical trials for Type 2 Diabetes Mellitus

Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM) on Monotherapy

Start date: January 2010
Phase: N/A
Study type: Interventional

This project will test the effectiveness of an Internet based glucose monitoring system on the A1C levels of patients with type 2 diabetes. All of the patients are given a meter and test strips to test their blood glucose levels, however, half of them will be required to also upload their meter onto the Internet which can then be viewed by their endocrinologist. The doctor can then send a message back to the patient and comment on the readings. The effect of the ongoing communication will be measured by the changes in the glucose levels (HbA1C) over 3 and 6 months.

NCT ID: NCT00948324 Suspended - Clinical trials for Type 2 Diabetes Mellitus

Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes

Start date: June 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate and evaluate the effects of different interventions (1.continuous subcutaneous insulin infusion,2.continuous subcutaneous insulin infusion combined with rosiglitazone 3.continuous subcutaneous insulin infusion combined with metformin,4.continuous subcutaneous insulin infusion combined with α- thioctic acid daily injections,) on glycemic control, B-cell function and the remission rate in newly-diagnosed type 2 diabetic patients.